Transcatheter aortic valve replacement in Korea yielded favorable procedural and survival outcomes, though overall medical costs remain substantial primarily due to device expenses.
TAVR adoption in Korea is increasing with favorable clinical outcomes, but device costs continue to drive substantial overall medical expenses.
Absolute Event Rate: 0% vs 0%
The number of TAVR recipients and performing centers in Korea has substantially increased over time. The procedural and survival outcomes were favorable. The overall medical costs for TAVR procedures are still substantial, mainly driven by device costs.
Lee et al. (Thu,) reported a other. Transcatheter aortic valve replacement in Korea yielded favorable procedural and survival outcomes, though overall medical costs remain substantial primarily due to device expenses.